Document Detail


Preparation and characterization of camptothecin solid lipid nanoparticles.
MedLine Citation:
PMID:  12026219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Camptothecin (CA), an antitumor drug, was incorporated into solid lipid nanoparticles (SLNs) prepared by high-pressure homogenization. A Taguchi orthogonal experimental design was used to study the influence of four different variables, with each variable having three value levels on nanoparticle size. Analysis of variance (ANOVA) has been used to evaluate the preparation of CA-SLNs and perform product optimization. The optimized CA-SLNs suspension was lyophilized using mannitol and glucose as cryoprotectants. The physicochemical characteristics of CA-SLNs were evaluated using transmission electron microscopy (TEM), electrophoresis, and differential scanning calorimetry (DSC). The release of camptothecin from CA-SLNs in various media was evaluated using a high-performance liquid chromatography (HPLC) method. The results showed that the concentration of emulsifier and the homogenization pressure had a significant influence on the particle size. The optimized CA-SLNs had an average diameter of about 200 nm, exhibited monodispersity with Dw/Dn of 1.06, and carried a negative charge. The optimal cryoprotectants consisted of 10% mannitol and 5% glucose in nanoparticle suspension. Lyophilized product was reconstituted in distilled water within 0.5 min without change of nanoparticle size. Camptothecin might exist in an amorphous state in SLNs. In vitro results showed that drug release was achieved for up to one week, and the released camptothecin quickly changed to open carboxylate form in the biological pH phosphate buffer. The results indicate that SLNs might be good potential sustained-release delivery vehicles for camptothecin or other lipophilic drugs.
Authors:
Shi Cheng Yang; Jia Bi Zhu
Related Documents :
2722309 - Biliary elimination of ticarcillin plus clavulanic acid (claventin): experimental and c...
12754529 - Assessment of nutritional rickets in western saudi arabia.
16653059 - Association of carbonic anhydrase activity with carboxysomes isolated from the cyanobac...
8365529 - What do we know about the origin of ca 125?
21504729 - Voltage-dependent gating underlies loss of enac function in pseudohypoaldosteronism typ...
21367859 - Base of the thumb domain modulates epithelial sodium channel gating.
22342689 - Structure, function and translational relevance of aquaporin dual water and ion channels.
3004409 - Cytidine monophosphate-dependent synthesis of phosphatidylglycerol in permeabilized typ...
1319569 - Basolateral membrane conductance in a6 cells: effect of high sodium transport rate.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug development and industrial pharmacy     Volume:  28     ISSN:  0363-9045     ISO Abbreviation:  Drug Dev Ind Pharm     Publication Date:  2002 Mar 
Date Detail:
Created Date:  2002-05-23     Completed Date:  2002-12-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802620     Medline TA:  Drug Dev Ind Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  265-74     Citation Subset:  IM    
Affiliation:
Zhongkun Pharmaceutical Research Institute, China Pharmaceutical University, Nanjing, Jiangsu, People's Republic of China. yangshicheng@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Camptothecin / chemical synthesis,  chemistry*,  pharmacokinetics
Capsules
Nanotechnology / methods*,  statistics & numerical data
Chemical
Reg. No./Substance:
0/Capsules; 7689-03-4/Camptothecin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of mixer torque rheometry to study the effect of formulation variables on the properties of ...
Next Document:  Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: ...